Kate Cronin (Moderna) | Pioneering Biotech Company and their Software of Life

Fall means it's time for your annual flu and Covid shots! So, this week on The CMO Podcast, Jim welcomes Kate Cronin, the Chief Brand Officer for Moderna, the 14-year-old pioneering biotech company. Moderna achieved nearly instant awareness and fame in 2020, when it received the CDC recommendation for its COVID-19 vaccine. Moderna’s name combines the words "modified" and "RNA" to signal the core essence of the company: to introduce a new category of medicines using messenger RNA, “the software of life.” Moderna has a market cap of about $25 billion, with projected revenue in 2024 in the range of $3 to $3.5 billion.Kate has combined her passion for science and marketing into a career path that bridges the two. She graduated from Smith College with a degree in biology, and started her career as a research associate at Weill Cornell Medicine in New York City. A few years later she jumped into the marketing world and has never left. Kate worked with healthcare clients at agencies Porter Novelli and Ogilvy for nearly 30 years; she left her position as CEO of Ogilvy Health about three years ago to become Chief Brand Officer at Moderna. As you look to book your own vaccine appointment, listen in for a conversation with a pioneering Chief Brand Officer–who likes to fix up old homes in her spare time!See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.